Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Arachidonoyl glycine-d8 (NAGly-d8) is intended for use as an internal standard for the quantification of NAGly by GC- or LC-MS. NAGly has been isolated from cell cultures treated with arachidonoyl ethanolamide (AEA), from extracts of mammalian brain, and has also been synthesized as an analog of AEA for structure/activity testing.1,2,3,4 NAGly may be produced endogenously via oxidation of AEA, or by transacylation of arachidonoyl coenzyme A. NAGly is reported to have analgesic activities in whole animal experiments.1,2,3 Since it seems to be a very poor ligand for the CB1 receptor, these effects are probably mediated via other signalling pathways.4
WARNING This product is not for human or veterinary use.
1. Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat. 61(1-2), 29-41 (2000).
2. Identification and characterization of an endogenous anandamide-
3. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. The Journal of Biological Chemisty 276(46), 42639-42644 (2001).
4. Structural requirements for binding of anandamide-